As a nation, we have committed ourselves to a long-term goal of becoming a developed country by 2047. Almost all the nations ...

Tesla, Inc. (NASDAQ:TSLA), the electric vehicle (EV) pioneer and technology innovator, continues to captivate investors and ...

Heterogeneity in prevalence estimates identified across studies and regions indicates that more research is required to draw stronger conclusions about the scale of OCSEA. However, the findings of ...

AI could drive a $7 trillion increase in global GDP, lifting productivity growth by 1.5 percentage points over 10 years.

Home sales have stalled in January, down 10% in the most recent week compared to a year ago, according to a new analysis by ...

Commercial-scale leases in the Gulf of Maine, a state research project and plans for a turbine-assembly port will be affected ...

Closing timelines for mortgages tend to rise and fall on a monthly basis with most mortgages closing in an average of 44 days ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

Despite some of the dips, Michigan Treasurer Rachael Eubanks said there are signs for optimism. Sales tax revenues, which ...

The 25 women who make up the new class of the Arkansas Delta Women’s Leadership Academy attended the first of six meetings on campus at Arkansas State University recently.

President Trump repealed outgoing President Biden's Executive Order that established comprehensive guidelines for the ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.